Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor or operator at the GP level to share in the promote and benefit from their expertise.

Co-GP / Platform:A family office could deploy into the Greater Boston life sciences market by backing a specialized operator at the GP level to share in the promote and benefit from a robust pipeline.

Co-GP / Platform:Family offices could deploy into the San Diego life science market by backing a sponsor or operator at the GP level, sharing in the promote and aligning interests to access a repeatable pipeline.

Co-GP / Platform:A family office could deploy into the UK Golden Triangle life sciences market by backing a sponsor or operator through co-GP or JV equity arrangements to share in the promote.

Co-GP / Platform:A family office could deploy into the Boston life sciences market by backing a sponsor/operator at the GP level, focusing on those with a strong track record in navigating market headwinds.

Co-GP / Platform:A family office could deploy into the New York City life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity to share in the promote.

Co-GP / Platform:A family office could deploy into the Bay Area life science market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of opportunities.

Co-GP / Platform:A family office could deploy into the Denver life sciences market by backing a sponsor or operator at the GP level, focusing on co-GP or JV equity structures to align interests and share in the promote.

Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a specialized operator at the GP level, sharing in the promote and benefiting from a robust pipeline.

Co-GP / Platform:A family office could deploy into the Chicago life sciences market by backing a sponsor/operator at the GP level, focusing on established developments like Fulton Labs.

Co-GP / Platform:A family office could deploy into the Washington, D.C. life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and accessing a pipeline of emerging opportunities.

Co-GP / Platform:A family office could deploy into the Chicago life sciences market by backing a sponsor/operator at the GP level, particularly in light of the high vacancy rates that may necessitate innovative leasing strategies.

Co-GP / Platform:A family office could deploy into this market by partnering with established life sciences operators in emerging markets to share in the promote and enhance their investment returns.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator at the GP level, sharing in the promote and benefiting from the strong pipeline of life sciences developments.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator at the GP level, focusing on life sciences projects that have been deferred or abandoned.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and benefiting from a strong deal flow.

Co-GP / Platform:A family office could deploy into the Seattle life sciences market by backing a sponsor/operator focused on innovative medical technologies to share in the promote.

Co-GP / Platform:A family office could deploy into the Philadelphia life sciences market by backing a sponsor/operator at the GP level, sharing in the promote and benefiting from a strong pipeline of developments.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor/operator at the GP level, particularly in funding developments like the HELIX life sciences campus.

Co-GP / Platform:A family office could deploy into the San Diego life sciences market by backing a sponsor/operator at the GP level, particularly in the development of new facilities like those at Pacific Center.

Co-GP / Platform:A family office could deploy into the San Francisco Bay Area life sciences market by backing a sponsor/operator at the GP level, capitalizing on the current high vacancy rates to negotiate favorable terms.

Co-GP / Platform:A family office could deploy into the New York life sciences market by backing a sponsor/operator involved in the development of new biotech facilities or leasing projects.

Co-GP / Platform:A family office could deploy into this market by backing a life sciences operator at the GP level, sharing in the promote and benefiting from the strong capital inflow.

Co-GP / Platform:A family office could deploy into this market by backing a sponsor like IQHQ or Boston Global Investors LLC at the GP level to share in the promote from their life sciences developments.